Binding of Proprotein Convertase Subtilisin/Kexin Type 9 to Epidermal Growth Factor-like Repeat A of Low Density Lipoprotein Receptor Decreases Receptor Recycling and Increases Degradation-Reference-Cited by-同舟云学术

Binding of Proprotein Convertase Subtilisin/Kexin Type 9 to Epidermal Growth Factor-like Repeat A of Low Density Lipoprotein Receptor Decreases Receptor Recycling and Increases Degradation

Published:2007-06 Issue:25 Volume:282 Page:18602-18612
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Zhang Da-Wei,Lagace Thomas A.,Garuti Rita,Zhao Zhenze,McDonald Meghan,Horton Jay D.,Cohen Jonathan C.,Hobbs Helen H.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference55 articles.

1. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

2. Molecular biology of PCSK9: its role in LDL metabolism

3. Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia

4. A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree

5. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9

Cited by 683 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Berberine: A Multi-Target Natural PCSK9 Inhibitor with the Potential to Treat Diabetes, Alzheimer’s, Cancer and Cardiovascular Disease;Current Reviews in Clinical and Experimental Pharmacology;2024-11

2. The kpc-1 3′UTR facilitates dendritic transport and translation efficiency of mRNAs for dendrite arborization of a mechanosensory neuron important for male courtship;PLOS Genetics;2024-08-07

3. Structural Dynamics of LDL Receptor Interactions with E498A and R499G Variants of PCSK9;2024-07-26

4. Assessment of serum proprotein convertase subtilisin/kexin type 9 in pediatric sepsis syndrome;Scientific Reports;2024-07-07

5. Instrumental variable and colocalization analyses identify endotrophin and HTRA1 as potential therapeutic targets for coronary artery disease;iScience;2024-07